Other means of limiting or correcting T1D include giving rapamycin [61], pluripotent stem cells [61,62], T-cell exhaustion [63], antigen-specific therapies [64,65], dipeptidyl peptidase-4 inhibitors, and proton-pump inhibitors [66]. The gene discussed is DPP4; the disease is type 1 diabetes mellitus.